Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2009
10/28/2009CN100553635C Pharmaceutical composition containing amoxicillin, ambroxol and beta lactamase inhibitor and uses thereof
10/28/2009CN100553631C Pharmaceutical uses of 4-fluoro-N-(1,2- hydrindenl-2-yl) benzamide
10/28/2009CN100553623C Chinese caterpillar fungus formulation preparation method
10/28/2009CN100553614C Preparation method of quickly disintegrating and dissolving solid medicine composition for oral cavity and its tablet
10/28/2009CN100553475C Feed additive containing the fruit of Chinese wolfberry
10/27/2009US7608718 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
10/27/2009US7608716 Pyrazolonaphthyridine derivative
10/27/2009US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608603 preferential enzyme inhibitors comprising fused pyrazolo pyrimidine derivatives used for treating arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608284 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli
10/27/2009US7608269 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
10/27/2009US7608257 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2437006C Aminotriazolopyridine derivatives as adenosine receptor ligands
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/27/2009CA2422210C Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
10/27/2009CA2421826C Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/27/2009CA2381165C Novel quinuclidine derivatives and medicinal compositions containing the same
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/27/2009CA2338141C Polymer complexes of glucuronoglucanes
10/22/2009WO2009129408A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/22/2009WO2009128558A1 Activator for peroxisome proliferator-activated receptor
10/22/2009WO2009128520A1 Heterocyclic compound having inhibitory activity on p13k
10/22/2009WO2009128481A1 Nitrogenated 5-membered heterocyclic compound
10/22/2009WO2009127833A1 Steroid nebuliser formulation
10/22/2009WO2009046827A3 Use of growth hormone-releasing factor and/or mage-3 antigen (271-279) as therapeutic agents
10/22/2009WO2009043518A3 Use of a combination of cart peptides as a therapeutic agent
10/22/2009WO2009040050A3 Use of calcitonin as anti-angiogenic agent
10/22/2009WO2009039982A3 Use of gip alone or in combination with dynorphin b as a therapeutic agent
10/22/2009WO2009039972A3 Use of muramyl dipeptide (mdp) as a therapeutic agent
10/22/2009WO2009033810A3 Use of antioxidant peptide a (phckrm) and aplha-casein (90-96) as therapeutic agents in eg the treatment of hiv infection
10/22/2009WO2009004339A3 Modulation of reactive oxygen species in the treatment of respiratory infection
10/22/2009US20090265798 Desaturase genes and uses thereof
10/22/2009US20090264503 Short interference ribonucleic acids for treating allergic diseases
10/22/2009US20090264501 Methods and Compositions to Inhibit P2x7 Receptor Expression
10/22/2009US20090264499 Cathepsin C Inhibitors
10/22/2009US20090264468 Methods for treating a disease in which Rho kinase is involved
10/22/2009US20090264461 Polymorph of (R)-3- (2-Hydroxy-2, 2-Diphenyl -Acetoxy) -1- (Isoxazol-s-ylcarbamoyl-methyl)-1-Azoni A-Bicyclo-[2.2.2] Octane Bromide
10/22/2009US20090264459 Organic Compounds
10/22/2009US20090264430 Salt of morpholine compound
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264399 Heterocyclic janus kinase 3 inhibitors
10/22/2009US20090264384 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
10/22/2009US20090264339 Heterocyclic Compounds
10/22/2009US20090263883 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
10/22/2009US20090263488 Pressurised metered dose inhalers containing solutions of beta-2 agonists
10/22/2009US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009US20090263389 Use of TGF-Beta Antagonists to Treat or to Prevent Chronic Transplant Rejection
10/22/2009US20090263381 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
10/22/2009US20090263333 Pharmaceutical compounds and compositions
10/22/2009US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines
10/22/2009CA2721339A1 Activating agent for peroxisome proliferator activated receptor
10/22/2009CA2721279A1 Steroid nebuliser formulation
10/22/2009CA2693001A1 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/21/2009EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009EP2110132A1 Use of deuterium oxide as elastase inhibitor
10/21/2009EP2109610A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
10/21/2009EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/21/2009EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof
10/21/2009EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
10/21/2009EP1423413B1 Peptidic compounds selectively binding to p-selectin
10/21/2009EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors
10/21/2009CN101563349A Haloalkyl-substituted pyrimidinone derivatives
10/21/2009CN101563091A Composition comprising crustacean gastrolith components and its use
10/21/2009CN101560253A Method for the crystallization of human serum albumin
10/21/2009CN101560208A Preparation method of pranlukast
10/21/2009CN101559186A Pharmaceutical composition for treating pulmonary tuberculosis, pneumonia and bronchitis
10/21/2009CN101559180A Drug for clearing away heat and toxic material, relieving cough, reducing phlegm and preventing asthma
10/21/2009CN101559170A Epidemics clearing and sore-throat relieving tea
10/21/2009CN101559130A Plant drug compound preparation for treating asthma in children and preparation thereof
10/21/2009CN101559126A Component composition with effect on curing sore throat
10/21/2009CN101559099A Traditional Chinese medicine composition for curing wind cold and preparation method thereof
10/21/2009CN101559046A Therapeutic action of micromolecule sugar alcohol composite on nasal disease
10/21/2009CN100551400C Medicine for treating bronchitis and asthma
10/21/2009CN100551398C Capsule for clearing lung heat to relieve cough
10/21/2009CN100551393C Honey polygala root and its preparation method
10/21/2009CN100551381C Traditional Chinese medicine agent for treating infantile bronchopneumonia
10/21/2009CN100551362C Shuanghuanglian effervescence tablet and preparation thereof
10/21/2009CN100551358C Method for making particles for use in a pharmaceutical composition
10/21/2009CN100551281C Preparing method of tobacco shred additives with tobacco poison-removing and healthy treatment efficacy
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7605153 Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
10/20/2009US7604955 Detection of peptides which induce cytotoxic t-lymphocytes; provide imunoglobulin test peptide, incubate with cells, monitor mammalian cytotoxic T- lymphocyte response, isolate peptide which induce response
10/20/2009US7604809 Reinforcing systemic immune responses with lactobacillus casei
10/20/2009CA2456127C Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
10/20/2009CA2389349C Aerosol composition comprising formoterol
10/20/2009CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009CA2336909C Thiobenzimidazole derivatives which are useful as inhibitors of human chymase activity
10/18/2009CA2662943A1 Inhalative and instillative use of semifluorinated alkanes as an active substance carrier in the intrapulmonary area
10/15/2009WO2009126912A1 Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
10/15/2009WO2009126682A2 Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
10/15/2009WO2009126606A2 Regression of established atherosclerotic plaques, and treating sudden-onset asthma attacks, using parp inhibitors
10/15/2009WO2009126530A2 Cgrp receptor antagonists
10/15/2009WO2009126513A1 Colchicine solid complex; methods of making; and methods of use thereof
10/15/2009WO2009125870A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers.
10/15/2009WO2009124962A2 Sulfonamides
10/15/2009WO2009124693A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy
1 ... 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 ... 878